ENTERA BIO IS-0000769 (5DT) — Cash Flow-to-Debt Ratio
ENTERA BIO IS-0000769 (5DT) has a Cash Flow-to-Debt Ratio of -0.63x as of December 2025, meaning its operating cash flow of €-1.83 Million could theoretically repay -1% of its total liabilities (€2.89 Million) in one year. See 5DT net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ENTERA BIO IS-0000769 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for ENTERA BIO IS-0000769 across 5 annual periods. Also explore 5DT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ENTERA BIO IS-0000769 (2021–2025)
Year-by-year debt coverage analysis for ENTERA BIO IS-0000769. For market capitalisation and broader financial context, see market value of ENTERA BIO IS-0000769.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.55x | €-7.37 Million | €2.89 Million | ▲ +51.0% |
| 2024 | -5.20x | €-6.82 Million | €1.31 Million | ▲ +1.8% |
| 2023 | -5.30x | €-7.31 Million | €1.38 Million | ▲ +41.8% |
| 2022 | -9.10x | €-12.50 Million | €1.37 Million | ▼ -243.7% |
| 2021 | -2.65x | €-9.06 Million | €3.42 Million | — |